- Home
- BFRG vs RANI Comparison
BFRG vs RANI Comparison
Compare BFRG & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- RANI
- Stock Information
- Founded
- BFRG 2017
- RANI 2012
- Country
- BFRG United States
- RANI United States
- Employees
- BFRG N/A
- RANI N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- RANI Medicinal Chemicals and Botanical Products
- Sector
- BFRG Technology
- RANI Health Care
- Exchange
- BFRG Nasdaq
- RANI Nasdaq
- Market Cap
- BFRG 16.4M
- RANI 17.0M
- IPO Year
- BFRG 2023
- RANI 2021
- Fundamental
- Price
- BFRG $1.51
- RANI $0.53
- Analyst Decision
- BFRG
- RANI Strong Buy
- Analyst Count
- BFRG 0
- RANI 4
- Target Price
- BFRG N/A
- RANI $7.75
- AVG Volume (30 Days)
- BFRG 204.8K
- RANI 4.6M
- Earning Date
- BFRG 08-06-2025
- RANI 08-05-2025
- Dividend Yield
- BFRG N/A
- RANI N/A
- EPS Growth
- BFRG N/A
- RANI N/A
- EPS
- BFRG N/A
- RANI N/A
- Revenue
- BFRG N/A
- RANI $1,200,000.00
- Revenue This Year
- BFRG N/A
- RANI N/A
- Revenue Next Year
- BFRG N/A
- RANI N/A
- P/E Ratio
- BFRG N/A
- RANI N/A
- Revenue Growth
- BFRG N/A
- RANI N/A
- 52 Week Low
- BFRG $1.23
- RANI $0.39
- 52 Week High
- BFRG $4.84
- RANI $3.75
- Technical
- Relative Strength Index (RSI)
- BFRG 49.22
- RANI 45.71
- Support Level
- BFRG $1.44
- RANI $0.40
- Resistance Level
- BFRG $1.58
- RANI $0.45
- Average True Range (ATR)
- BFRG 0.07
- RANI 0.07
- MACD
- BFRG 0.01
- RANI -0.00
- Stochastic Oscillator
- BFRG 46.94
- RANI 21.61
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.